Thursday, February 9, 2012

LD SCIENTIST. A young woman in Chicago was featured in the Chicago Tribune for overcoming LDs and difficulties in her family life to achieve success in the field of science. She is now applying to PhD programs to study microbiology, having established her talents and determination doing research at a lab at the University of Chicago. Read the article
AD/HD MEDS. This week the Child Mind Institute published an article on the side effects of AD/HD stimulant medication, including sleep problems, eating problems, the rebound effect, and cardiac risks. Find the article.
WHAT MAKES A GREAT TEACHER? Diane Rehm and four guests discussed that question in an NPR show on February 9th. Find the show.
THE GIFTED DEVELOPMENT CENTER has released its February newsletter. In it, GDC announces that it has been asked to validate extended norms on the Wechsler Preschool and Primary Scale of Intelligence IV. GDC is looking for children 2.6 to 7.6 to test for this validation in a number of cities across the U.S. Find out  more in the newsletter.
THE LD ONLINE NEWSLETTER for February is out, featuring the topic of improving comprehension for kids with LDs. Find it.
ATTENTION RESEARCH UPDATE. David Rabiner has posted this most recent issue of his newsletter. In it, Rabiner discusses a review of neurofeedback treatment for AD/HD. While Rabiner suggests that the review indicates that there may be beneficial effects to neurofeedback for AD/HD, apparently limitations on the studies reviewed allow the effects of neurofeedback to be classified as only "probably efficacious" rather than "efficacious" or "efficacious and specific." Read Attention Research Update.
AND FINALLY, THIS. Carla Crutsinger, founder of Brainworks, an organization in Texas that provides services to twice-exceptional children and families, recently lost her husband to cancer. In a personal edition of the Brainworks newsletter, she describes the family's travails over the past several years. Find the newsletter and then maybe send your best wishes.

No comments: